Lars Søegaard Nielsen
Lars Søegaard Nielsen publishes mostly in Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Monoclonal and Polyclonal Antibodies Research, Protease and Inhibitor Mechanisms and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #1,773,501 of 7,710,434 ranked researchers
- Rank in Denmark
- #13,413 of 43,819
- Works
- 35
- Citations
- 1.7k
- Citations per work
- 48.6
What does Lars Søegaard Nielsen research?
Lars Søegaard Nielsen's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1439.9%
- Medicine1439.9%
- Life Sciences1234.5%
- Everything else925.6%
- 1Hematology19% of their works
- 2Molecular Biology15% of their works
- 3Radiology, Nuclear Medicine and Imaging14% of their works
- 4Cancer Research13% of their works
- 5Immunology and Allergy6% of their works
- 6Immunology6% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Protease and Inhibitor Mechanisms
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Cell Adhesion Molecules Research
- Protein purification and stability
- Viral Infectious Diseases and Gene Expression in Insects
- Peptidase Inhibition and Analysis
Which keywords describe Lars Søegaard Nielsen's research?
The keywords of their largest research topics: Angiogenesis, Extracellular Matrix, Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Inflammation, Antibody Engineering and Fc Receptors.
- Tumor Microenvironment
- Mammalian Cells
- Protein Aggregation
- Integrins
- Factor VIII
- Thrombin
- Tissue Inhibitors of Metalloproteinases
- Fc Receptors
- Inflammation
- Therapeutic Antibodies
- Extracellular Matrix
- Angiogenesis
- Monoclonal Antibodies
- Glycosylation
- Antibody Engineering
- Matrix Metalloproteinases
- Protease-Activated Receptors
- Cell Adhesion
- Hemophilia
- Biopharmaceuticals
- Fibroblast Activation Protein
- Recombinant Protein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Angiogenesis223 topics
- Extracellular Matrix182 topics
- Monoclonal Antibodies182 topics
- Therapeutic Antibodies182 topics
- Glycosylation172 topics
- Inflammation172 topics
- Antibody Engineering131 topic
- Fc Receptors131 topic
- Matrix Metalloproteinases121 topic
- Tissue Inhibitors of Metalloproteinases121 topic
- Protease-Activated Receptors111 topic
- Thrombin111 topic
- Cell Adhesion61 topic
- Factor VIII61 topic
- Hemophilia61 topic
- Integrins61 topic
- Biopharmaceuticals51 topic
- Protein Aggregation51 topic
- Fibroblast Activation Protein41 topic
- Mammalian Cells41 topic
- Recombinant Protein41 topic
- Tumor Microenvironment41 topic
Where does Lars Søegaard Nielsen work?
Lars Søegaard Nielsen's main affiliation in the publication record is Symphogen (Denmark), Denmark.
How many publications and citations does Lars Søegaard Nielsen have?
OpenAlex counts 35 works and 1,701 citations for Lars Søegaard Nielsen, an h-index of 21, ranking #1,773,501 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lars Søegaard Nielsen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.